Drug Profile
Lamivudine/zidovudine + efavirenz tablets - Mylan Pharmaceuticals
Alternative Names: Zidovudine/lamivudine tablets + efavirenz tablets - Mylan PharmaceuticalsLatest Information Update: 11 Dec 2018
Price :
$50
*
At a glance
- Originator Mylan Pharmaceuticals
- Class Alkynes; Antiretrovirals; Azides; Benzoxazines; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Submission Withdrawal HIV-1 infections
Most Recent Events
- 11 Dec 2018 Chemical structure information added